Trial record 19 of 53 for:
"Breast Carcinoma in Situ" | "Hormones"
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04046159 |
|
Recruitment Status :
Recruiting
First Posted : August 6, 2019
Last Update Posted : August 6, 2019
|
Sponsor:
National Taiwan University Hospital
Collaborators:
Tri-Service General Hospital
Koo Foundation Sun Yat-Sen Cancer Center
Kaohsiung Medical University
Kyoto University
Mackay Memorial Hospital
Information provided by (Responsible Party):
National Taiwan University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 31, 2025 |
| Estimated Study Completion Date : | December 31, 2025 |